Journal abstracts: hypoglycemic effects of turmeric (Curcuma Longa L. Rhizomes) on genetically diabetic KK-AY mice.
The turmeric (Curcuma longa L. rhizomes) EtOH extract significantly suppressed an increase in blood glucose level in type 2 diabetic KK-A(y) mice. In an in vitro evaluation, the extract stimulated human adipocyte differentiation in a dose-dependent manner and showed human peroxisome proliferator-activated receptor (PPAR)-gamma ligand-binding activity in a GAL4-PPAR-gamma chimera assay. The main constituents of the extract were identified as curcumin, demethoxycurcumin, bisdemethoxycurcumin, and ar-turmerone, which had also PPAR-gamma ligand-binding activity. These results indicate that turmeric is a promising ingredient of functional food for the prevention and/or amelioration of type 2 diabetes and that curcumin, demethoxycurcumin, bisdemethoxycurcumin, and ar-turmerone mainly contribute to the effects via PPAR-gamma activation.
Biol Pharm Bull. 2005 May;28(5):937-9
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 1, 2010|
|Previous Article:||Journal abstracts: metabolic dysfunction and chronic stress: a new sight at "Diabesity" pandemic.|
|Next Article:||Journal abstracts: effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes.|